Heather Madsen holds a PhD in Evolutionary Genetics and joined the pharmaceutical industry in 2001. During her 22-year career at GSK and ViiV Healthcare, Heather held a variety of leadership roles including Head of R&D for the European Pharma Diagnostics Business Unit, Senior Director of Target Sciences Infectious Disease, and Executive Director of Research for Alternative Discovery & Development. She led a diversity of Pharma projects spanning early R&D to Post-Marketing, is co-author of 40 peer-reviewed scientific publications and is co-inventor of 3 patents. In her last role at GSK/ViiV as Head of Translational Research, she created a ViiV Bioinformatics function and led the HIV cure research area including a biotech collaboration with UNC Chapel Hill, Qura Therapeutics. Heather joined Hatteras Venture Partners in February 2024 where she is currently an Operating Partner, Board Observer of Huma.ai, Independent Board Member of Inimmune, and President of a stealth-mode precision immunology biotech.
